BIIB
Price:
$200.81
Market Cap:
$29.25B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of AN...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1991-09-17
Stock Exchange
NASDAQ
Ticker
BIIB
According to Biogen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 34.19B. This represents a change of -15.66% compared to the average of 40.55B of the last 4 quarters.
The mean historical Enterprise Value of Biogen Inc. over the last ten years is 59.32B. The current 34.19B Enterprise Value has changed 5.66% with respect to the historical average. Over the past ten years (40 quarters), BIIB's Enterprise Value was at its highest in in the March 2015 quarter at 98.33B. The Enterprise Value was at its lowest in in the June 2022 quarter at 34.66B.
Average
59.32B
Median
62.55B
Minimum
41.11B
Maximum
79.61B
Discovering the peaks and valleys of Biogen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 20.21%
Maximum Annual Enterprise Value = 79.61B
Minimum Annual Increase = -22.17%
Minimum Annual Enterprise Value = 41.11B
Year | Enterprise Value | Change |
---|---|---|
2023 | 43.73B | 0.69% |
2022 | 43.43B | 5.64% |
2021 | 41.11B | -10.42% |
2020 | 45.89B | -22.17% |
2019 | 58.97B | -11.15% |
2018 | 66.37B | -7.93% |
2017 | 72.09B | 9.03% |
2016 | 66.12B | -12.87% |
2015 | 75.89B | -4.68% |
2014 | 79.61B | 20.21% |
The current Enterprise Value of Biogen Inc. (BIIB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
42.76B
5-year avg
46.63B
10-year avg
59.32B
Biogen Inc.’s Enterprise Value is less than Bristol-Myers Squibb Company (146.44B), less than AbbVie Inc. (399.11B), less than Merck & Co., Inc. (325.14B), less than Gilead Sciences, Inc. (118.58B), less than Johnson & Johnson (412.32B), less than Amgen Inc. (225.59B), less than Pfizer Inc. (230.24B), less than Sanofi (147.45B), less than Novartis AG (249.31B), less than GSK plc (81.81B),
Company | Enterprise Value | Market cap |
---|---|---|
146.44B | $98.73B | |
399.11B | $341.61B | |
325.14B | $298.70B | |
118.58B | $98.01B | |
412.32B | $395.70B | |
225.59B | $172.25B | |
230.24B | $161.84B | |
147.45B | $144.70B | |
249.31B | $228.22B | |
81.81B | $89.06B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biogen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Biogen Inc.'s Enterprise Value?
What is the highest Enterprise Value for Biogen Inc. (BIIB)?
What is the 3-year average Enterprise Value for Biogen Inc. (BIIB)?
What is the 5-year average Enterprise Value for Biogen Inc. (BIIB)?
How does the current Enterprise Value for Biogen Inc. (BIIB) compare to its historical average?